Silver Spike Acquisition Corp. II (SPKB) to Combine with Eleusis in $446M Deal
Silver Spike II (NASDAQ:SPKB) has entered into a definitive agreement to combine with pharmaceutical firm Eleusis at an enterprise value of $446 million. New York City-based Eleusis is developing a novel therapy for treatment-resistant depression involving IV-administered psychadelics. The combined company is expected to trade on the Nasdaq under the symbol “ELEU” once the dealRead More